About this trial
The goal of this clinical trial is to determine if adding avocados to the diet of impacts cognition in 70 older adults, age 65-85, without dementia. We will test for change in functional MRI, cognitive performance, and brain blood flow. Intervention group participants will be asked to consume 1 avocado per day for 12 weeks. Participants in the control group will be asked to continue their normal intake for 12 weeks. Throughout the study, participants will be asked to perform cognitive tests, MRI, blood tests, and questionnaires.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Males and females aged 65-85 years
Good general health with no concomitant disease
BMI 18.5 - 35 kg/m2
Mini Mental State Exam ≥26
Disqualifiers
Unwilling or unable to consume avocado
Latex allergy
Consistently taking lutein + zeaxanthin supplements
Skin carotenoid content ≥400
Trial design
Parallel
Treatments tested in this trial
Avocado Group
Other interventionParticipants will consume provided avocados daily and track consumption for the duration of the study. Participants will be adding avocados to their diet and will receive education on maintaining usual diet.
Treatment groups
Trial outcomes
Primary outcomes
Change in brain activity
MRI will be used to measure changes in brain activity during resting state, a working memory task, and executive function task.
Secondary outcomes
Changes in cerebral blood flow
MRI will be used to measure change in cerebral blood flow.
Changes in memory and executive function
NIH Toolbox will be used to measure change in cognition throughout the study.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Kansas Medical Center
Lead sponsor
Avocado Nutrition Center
Collaborator